Skip to main content
logo
Brii Biosciences Limited (HKG:2137)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.400
+0.010 (0.72%)
At close: Mar 27, 2026

Brii Biosciences Revenue

In the year 2025, Brii Biosciences had annual revenue of 35.55M CNY, down -28.81%. Brii Biosciences had revenue of 34.56M in the half year ending December 31, 2025, with 118.79% growth.

Revenue
35.55M CNY
Revenue Growth
-28.81%
P/S Ratio
25.54
Revenue / Employee
370.29K CNY
Employees
96
Market Cap
1.01B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202535.55M-14.39M-28.81%
Dec 31, 202449.94M-5.96M-10.65%
Dec 31, 202355.89M-66.39M-54.29%
Dec 31, 2022122.28M29.74M32.13%
Dec 31, 202192.54M10.32M12.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Uni-Bio Science Group589.59M
3D Medicines491.34M
JW (Cayman) Therapeutics Co.315.65M
Wuhan YZY Biopharma163.65M
CANbridge Pharmaceuticals68.55M
Beijing Biostar Pharmaceuticals58.66M
Shanghai Bio-heart Biological Technology50.00M
Kintor Pharmaceutical12.04M
Revenue Rankings

Brii Biosciences News

More News